Rela Hospital is excited to announce a groundbreaking treatment in the battle against NXP2 Dermatomyositis, a rare and challenging autoimmune disease. A team of dedicated medical professionals and experts has achieved this unprecedented success bringing hope and relief to patients and their families worldwide.
NXP2 Dermatomyositis is an exceptionally challenging disease that affects a small proportion of individuals worldwide. It is characterized by the presence of autoantibodies against the NXP2 protein, leading to severe inflammation of muscles and skin.
It all began when Dr. Gautam, a dedicated army professional, started experiencing stiffness in his joints accompanied by body aches. Initially attributing it to osteoarthritis, he sought the advice of a trusted colleague, an orthopedic surgeon, who recommended simple analgesics however despite a month of treatment, his symptoms persisted, leading him to seek further medical assistance. That’s when Dr. Gautam approached Dr. (BRIG) Shanmuganandan, Rheumatologist at Rela Hospital. Recognizing the urgency of the situation, Dr. Shanmuganandan promptly ordered a series of tests to identify the underlying cause. Through meticulous examination and state-of-the-art investigative modalities available at Rela Hospital, the medical team identified a rare medical illness known as NXP2 Dermatomyositis. Early diagnosis was made possible by a thorough understanding of Dr. Gautam’s medical history and diligent clinical care.
The key breakthrough lies in the development of targeted immunomodulatory treatments that address the underlying autoimmune mechanism responsible for NXP2 Dermatomyositis. The treatments aim to suppress the abnormal immune response, reduce inflammation, and restore normal muscle and skin function resulting in significant improvements in patients’ overall well-being, including reduced muscle weakness, improved mobility, and enhanced skin health.
“Responding remarkably well to treatment, Dr. Gautam experienced a complete resolution of his earlier symptoms, bringing immense relief. However, his journey took an unexpected turn when he was diagnosed with tuberculosis in January. Once again, the exceptional clinical care, precise investigations, and cutting-edge treatment at Rela Hospital played a crucial role in identifying and treating this new challenge,” said Dr. (BRIG) Shanmuganandan, Rheumatologist at Rela Hospital.
“Thanks to the dedicated efforts of Dr. Aishwarya, Dr. Sathya, Dr. (BRIG) Shanmuganandan, Dr. Vidyalakshmi Devarajan, and the entire healthcare team, I was diagnosed and treated with unparalleled expertise. Throughout my stay, spanning nearly ten days, I received comprehensive care from specialists, including vascular surgeons and hematologists. I am now leading a symptom-free life with complete remission of my illnesses,” commented Dr. Gautam.
About Rela Hospital
Rela Hospital, an International Medical facility, is a quaternary care hospital dedicated to fostering and responding to the needs of a diverse patient population. The hospital provides high-quality healthcare with state-of-the-art infrastructure facilities and experienced, caring medical professionals.
RIMC is designed to provide multi-specialty care with a special focus on multi-organ transplantation and critically ill patients. In addition to quaternary care in all specialties, the hospital is committed to providing day-to-day “primary and secondary care” to patients. RIMC is a multi-super specialty hospital in a sprawling landscape of 36 acres located in Chromepet, Chennai, Tamil Nadu, India.
• The facility, with 450 beds inclusive of 130 critical-care beds, 14 operating rooms, and sophisticated reference laboratories and radiology services, is conveniently located close to the road, rail, and air transport.
• RIMC is led and managed by world-renowned doctors who are committed to healthcare.
• RIMC offers a wide spectrum of clinical care, education, and research.
